These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Angiotensin II-induced increase in myocardial distensibility and its modulation by the endocardial endothelium in the rabbit heart. Castro-Chaves P; Fontes-Carvalho R; Pintalhao M; Pimentel-Nunes P; Leite-Moreira AF Exp Physiol; 2009 Jun; 94(6):665-74. PubMed ID: 19346335 [TBL] [Abstract][Full Text] [Related]
4. Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling. Fontes-Sousa AP; Brás-Silva C; Pires AL; Monteiro-Sousa D; Leite-Moreira AF Naunyn Schmiedebergs Arch Pharmacol; 2007 Oct; 376(1-2):107-15. PubMed ID: 17701026 [TBL] [Abstract][Full Text] [Related]
5. Endothelin ETA receptors and endothelium partially mediate the positive inotropic and lusitropic effects of angiotensin II. Castro-Chaves P; Roncon-Albuquerque R; Leite-Moreira AF Eur J Pharmacol; 2006 Aug; 544(1-3):91-6. PubMed ID: 16842775 [TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 and angiotensin-II modulate urotensin-II vasoconstriction in rat aorta exposed to mercury. Ahmed AH; Maulood IM Bratisl Lek Listy; 2018; 119(7):444-449. PubMed ID: 30160135 [TBL] [Abstract][Full Text] [Related]
7. Obligatory role of the endocardial endothelium in the increase of myocardial distensibility induced by endothelin-1. Brás-Silva C; Leite-Moreira AF Exp Biol Med (Maywood); 2006 Jun; 231(6):876-81. PubMed ID: 16741016 [TBL] [Abstract][Full Text] [Related]
8. [Peroxisome proliferator-activated receptor activator troglitazone inhibits angiotensin II-stimulated secretion of vasoactive factors by endothelial cells]. Li YQ; Niu XL; Wang CX; Wei J; Wang SJ; Zhou J Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1030-3. PubMed ID: 17666345 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the myocardial endothelin system by angiotensin-II and losartan. McEwan PE; Sherry L; Kenyon CJ; Webb DJ; Gray GA J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S144-7. PubMed ID: 11078361 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characteristics of endothelin receptors in the rabbit ventricular myocardium: the nonselective endothelin receptor antagonist PD 145065 antagonizes the positive inotropic effect of endothelin-3 but not of endothelin-1. Norota I; Endoh M Mol Cell Biochem; 1996; 160-161():67-74. PubMed ID: 8901457 [TBL] [Abstract][Full Text] [Related]
11. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II. D'Amours M; Lebel M; Grose JH; Larivière R Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660 [TBL] [Abstract][Full Text] [Related]
12. Myocardial contractile responsiveness to endothelin-1 in the post-infarction rat model of heart failure: effects of chronic quinapril. Qi XL; Sia YT; Stewart DJ; Wei G; Nguyen QT; Cernacek P; Picard P; Sirois M; Rouleau JL J Mol Cell Cardiol; 2001 Nov; 33(11):2023-35. PubMed ID: 11708846 [TBL] [Abstract][Full Text] [Related]
13. ET-1 increases distensibility of acutely loaded myocardium: a novel ETA and Na+/H+ exchanger-mediated effect. Leite-Moreira AF; Bras-Silva C; Pedrosa CA; Rocha-Sousa AA Am J Physiol Heart Circ Physiol; 2003 Apr; 284(4):H1332-9. PubMed ID: 12595285 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and prostaglandins - important players in endothelin-1 induced myocardial distensibility. Brás-Silva C; Monteiro-Sousa D; Duarte AJ; Guerra M; Fontes-Sousa AP; Moura C; Areias JC; Leite Moreira AF Physiol Res; 2008; 57(2):165-174. PubMed ID: 17552879 [TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure. Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Nicholls MG; Richards AM Clin Sci (Lond); 2004 Jun; 106(6):569-76. PubMed ID: 14723602 [TBL] [Abstract][Full Text] [Related]
16. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. Cheng TH; Cheng PY; Shih NL; Chen IB; Wang DL; Chen JJ J Am Coll Cardiol; 2003 Nov; 42(10):1845-54. PubMed ID: 14642698 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor. Lin YJ; Kwok CF; Juan CC; Hsu YP; Shih KC; Chen CC; Ho LT Biochem Biophys Res Commun; 2014 Aug; 451(2):263-9. PubMed ID: 25088996 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II mediates urotensin II expression by hypoxia in cultured cardiac fibroblast. Shyu KG; Wang BW; Chen WJ; Kuan P; Lin CM Eur J Clin Invest; 2012 Jan; 42(1):17-26. PubMed ID: 21627650 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the myocardial effects of selective ETB receptor stimulation and its implications for heart failure. Brás-Silva C; Leite-Moreira AF Rev Port Cardiol; 2005 Sep; 24(9):1125-33. PubMed ID: 16335286 [TBL] [Abstract][Full Text] [Related]
20. Evidence for the involvement of endothelin-1 but not urotensin-II in chronic lower limb ischaemia in man. Tsui JC; Baker DM; Biecker E; Shaw S; Dashwood MR Eur J Vasc Endovasc Surg; 2003 May; 25(5):443-50. PubMed ID: 12713784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]